Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Cost-effectiveness of bladder cancer screening
Yair Lotan
,
Robert S. Svatek
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cost-effectiveness of bladder cancer screening'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Urine
100%
Bladder Cancer
100%
Man
100%
Diseases
50%
Malignant Neoplasm
50%
Smoking
50%
Screening
50%
Tumor Marker
50%
Early Cancer Diagnosis
50%
High Risk Population
50%
Evaluation Study
50%
Survival
50%
Blood
50%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Bladder Cancer
100%
Patient
100%
Diseases
50%
Screening
50%
Prognosis
50%
High Risk Population
50%
Malignant Neoplasm
50%
Cancer Screening
50%
Early Cancer Diagnosis
50%
Tumor Marker
50%
Evaluation Study
50%
Survival
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Diseases
50%
Prognosis
50%
Malignant Neoplasm
50%
Tumor Marker
50%
Survival
50%
Biochemistry, Genetics and Molecular Biology
Screening
50%
Smoking
50%
Tumor Marker
50%
High Risk Population
50%
Cancer Screening
50%
Survival
50%